10. Results of network meta‐analysis for outcome adverse event: hypocalcemia. Prediction intervals. Treatments are ordered by P‐score (descending).
95% prediction intervals (risk ratios, random‐effects model) | ||||
No treatment/placebo | [ 0, 1576.09 ] | [ 0.01, 654.71 ] | [ 0, 35260.46 ] | [ 0.01, 4541.37 ] |
[ 0, 405.24 ] | Clodronate | [ 0, 710.22 ] | [ 0, 64752 ] | [ 0, 4419.4 ] |
[ 0, 116.04 ] | [ 0, 489.59 ] | Zoledronic acid | [ 0, 28482.19 ] | [ 0.01, 688.08 ] |
[ 0, 3662.25 ] | [ 0, 26156.52 ] | [ 0, 16690.04 ] | Risedronate | [ 0, 75668.22 ] |
[ 0, 137.66 ] | [ 0, 521.01 ] | [ 0, 117.67 ] | [ 0, 22083.49 ] | Denosumab |